Shefah Qazi

June 12, 2023

Shefah has 14 years of multi-disciplinary experience spanning biochemistry, bioengineering, molecular biology, and cell biology. At Pheast, Shefah studies protein characteristics and functionality in the setting of immuno-oncology. Prior to joining Pheast, she served as a Scientist at Gritstone Bio, where she established a mammalian expression system for MHC class I and class II monomers, engineered the proteins for higher recovery and stability, and managed the production of pHLAs to support preclinical and clinical work in the discovery of therapeutic antibodies and vaccine candidates. Shefah’s post-doctoral research involved using viral structural proteins as antiviral targets and investigating the effects of viral spike proteins in different cell types in various disease pathologies. Shefah’s doctoral research focused on engineering viral nanoparticles for applications in gene editing and medical imaging. Shefah received a Ph.D. in biochemistry from Montana State University and a B.S. in chemistry from the University of California, Berkeley.